OPKO Health, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
OPKO Health, Inc. (OPK) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.81% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-02-26
- OPKO Health, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 0.81%.
- OPKO Health, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -412.80%.
- OPKO Health, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -2.40%, a 114.81% decline from fiscal 2022.
- OPKO Health, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 16.20%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.81% 10-K · filed 2026-02-26 | |
| 2024-12-31 | -412.80% 10-K · filed 2025-03-03 | |
| 2023-12-31 | -2.40% 10-K · filed 2025-03-03 | |
| 2022-12-31 | 16.20% 10-K · filed 2025-03-03 | -1.00% 10-K · filed 2023-02-27 |
| 2021-12-31 | -105.70% 10-K · filed 2024-03-01 | 9.70% 10-K · filed 2022-03-01 |
| 2020-12-31 | 3.20% 10-K · filed 2023-02-27 | |
| 2019-12-31 | 0.10% 10-K · filed 2022-03-01 | 0.00% 10-K · filed 2020-03-02 |
| 2018-12-31 | -0.80% 10-K · filed 2021-02-18 | -0.70% 10-K · filed 2019-03-01 |
| 2017-12-31 | -0.40% 10-K · filed 2020-03-02 | -1.00% 10-K · filed 2018-03-01 |
| 2016-12-31 | -7.70% 10-K · filed 2019-03-01 | -8.70% 10-K · filed 2017-03-01 |
| 2015-12-31 | -1.00% 8-K · filed 2019-01-29 | -1.70% 10-K · filed 2016-02-29 |
| 2014-12-31 | 0.80% 10-K · filed 2017-03-01 | |
| 2013-12-31 | -3.90% 10-K · filed 2016-02-29 | |
| 2012-12-31 | -0.70% 10-K · filed 2015-02-27 | -12.10% 10-K · filed 2013-03-18 |
| 2011-12-31 | 2.00% 10-K · filed 2014-03-03 | 37.90% 10-K · filed 2013-03-18 |
| 2010-12-31 | -50.70% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |